{"name":"Cassiopea SpA","slug":"cassiopea-spa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"CB-03-01 cream, 1%","genericName":"CB-03-01 cream, 1%","slug":"cb-03-01-cream-1","indication":"Acne vulgaris","status":"phase_3"},{"name":"Clascoterone 5% solution","genericName":"Clascoterone 5% solution","slug":"clascoterone-5-solution","indication":"Acne vulgaris","status":"phase_3"}]}],"pipeline":[{"name":"CB-03-01 cream, 1%","genericName":"CB-03-01 cream, 1%","slug":"cb-03-01-cream-1","phase":"phase_3","mechanism":"CB-03-01 is an androgen receptor antagonist that blocks the effects of androgens in the skin to reduce sebum production and inflammation associated with acne.","indications":["Acne vulgaris"],"catalyst":""},{"name":"Clascoterone 5% solution","genericName":"Clascoterone 5% solution","slug":"clascoterone-5-solution","phase":"phase_3","mechanism":"Clascoterone is an androgen receptor antagonist that blocks androgen signaling in skin to reduce sebum production and acne lesions.","indications":["Acne vulgaris"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPUFByRlREb1F6UmxGdGVMajFQQmNxTHNOcTVQWlRBTWJnQzF5OUd4cmJDOHhKVjduNmdta3Z1dUp2Ykt3OEhrME4yQzdOSndHa2JiYWdhcXRmM2J5UHpmZGZfUm1iTkpFUjg5NXN4U1BzTDN2a0FEajJuM01hZG9CYW91ZDNOMzE4NjlQajkzZ3B0R3pKai10T3NFSFlhMnhzWGFPclNsckxyY0cxempYTjJrdkhZX3M2enVmTV9Bc09SSzhGNUlKUWc4Mklrdw?oc=5","date":"2025-02-11","type":"deal","source":"BW Healthcare World","summary":"Sun Pharma Acquires Exclusive Right To Commercialise Winlevi Acne Cream In US, Canada - BW Healthcare World","headline":"Sun Pharma Acquires Exclusive Right To Commercialise Winlevi Acne Cream In US, Canada","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2021-11-02","type":"pipeline","source":"ET HealthWorld","summary":"Sun Pharma launches acne treatment cream Winlevi in US market - ET HealthWorld","headline":"Sun Pharma launches acne treatment cream Winlevi in US market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAJBVV95cUxQYzF3RGhMWHg4bG1WZ1Z3bXh0WEtEQ0J0eFJUUE9VRnF3VnhlOE94WWRWUzRyc3hhMDBlOEI2MFhmeTFiaHJZWXZqWTYwN0VycDNyLXlzazh1VmNZbkwxc21NZ2xRdDQtQ2xUMVVvQXh4X00zR3A1UnU2VDdfTnU5aVBwRC1yM1dyRTNTWlBBakpxTHFYSzRMemZuV211Tm5fZGlMRmtBR3ZJTHI1c1FpYnJJYTdJbTNIdV9keVhSOGtWM295Y0hSUk93Q1hqVGFKSVk1N0Rhcm4wSzNTSzF4QU5SbTFPamNQZVFlc1hUa2tqTUFxMi1ETlpibWN5YjZvUmxxUEloR09IWTNB?oc=5","date":"2021-08-31","type":"patent","source":"BioSpace","summary":"Sun Pharma and Cassiopea announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (clascoterone cream 1%) agreement - BioSpace","headline":"Sun Pharma and Cassiopea announce the expiry of the HSR Act process and the successful consummation of their Winlevi® (c","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgJBVV95cUxPdTRVdHlnZmtqVmN4WTlhMjJGbWpTbFdwbmxfWkFiVU9aRFFnNHllazRVeHl0d2hwaFpLcUlyLUFqOUtJSjNqa3lteFpkU2c0QUx6TDJKdG9CQmZJMk4wZ040TFcxQl9UaEVmVFVBYkNqRWFTaWwzaEs0TW45cktpTThOU2NicHB1T3hDZWYzRm0zdUpYemJHS2l2dGxqTEx5Ni1CaU9MbGs1eGdQaXF4SjdkU0hwMHVERndqazl6T3pjNmFtaE5HbWwzT2FzSlNxc3NQbHVxU1doUFQ1eVJjUXRNNG9LdXJramtlSGwyTXljM1E3VlAzSWdCZnpBX1Z1dEZpRWJ3R05kSUYxX2czeGh3?oc=5","date":"2021-07-26","type":"deal","source":"prnewswire.com","summary":"Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in US and Canada - prnewswire.com","headline":"Sun Pharma and Cassiopea SpA Announce Signing of License and Supply Agreements for Winlevi® (clascoterone cream 1%) in U","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxPdllUY19IbUxiNGpkLUFSUHhIRVhkeXBpaTM0WW9BRUZmVUlwWUdjR0dtTXNma2dwZDdoWXZQZkM4Rk0ybWU3QVdEVmdUb0M2ZU9STG1vX3VJbkt0aVVGSU0zLWx3ZWhGNU1WYXNSQjBDVTNpMUR1WG1HMkdpZDdnc0ltSVNDb2dTdE5qcXg5d2VTNWc0WXp5Yld1dlUwX1BXU2ZjaUhVaXpNQXc3WFlDbWxiV21zaWFQVUtJVmthQkVPaDB0ODMzakVlQnhUVVRJTDlpOEQydmV4QVNFOC1xT0pXc1IyWFpyaTRRNdIB-gFBVV95cUxONExQbEg5QmtZYVBneWxWSy1IZWFLRU9HYVRFcDN2Snl0b0ZOdWRBb2xGNnoxNVNFUGhNR3FpSnlLQXF0VUhBWGFNeFJQT0tTZ0JGb0NDUFBhV2k0aWxPZkxWdmxCYjFBTm4yOUR3c0pZLVFVaTR1S29VMGZRajBCczJBcUtxRjNVUVM5Y2toclBTSHRBRnhldXg2cF9aMm1hM013SmN0bnRxZ2FjRXppUUNybVZpU1ZWYUZtYUpCQUVRdWFGLTFUaS1xSTNKLTZ6dW45dmdVLVR6d0VLUnJLRzQtSlg2YnRtSUxXTzhIcV95UzNxbmlvYlpB?oc=5","date":"2021-07-26","type":"deal","source":"The New Indian Express","summary":"Sun Pharma, Cassiopea SpA ink license and supply agreements for acne treatment drug Winlevi - The New Indian Express","headline":"Sun Pharma, Cassiopea SpA ink license and supply agreements for acne treatment drug Winlevi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE10NmJ1YjE4dnZRbVVZd0dYbE9pYVZuM25hNUlOZjJEVmRCNWJmdDNwM3g5azVzYUkxUjhxcVM5Z0xraVlmcm9tYjhXRDZmS2tZdGY2R0FrUVRXSWR4SnlV?oc=5","date":"2020-12-02","type":"pipeline","source":"Nature","summary":"Cassiopea S.p.A.: Elevating the science of dermatology with new therapeutics - Nature","headline":"Cassiopea S.p.A.: Elevating the science of dermatology with new therapeutics","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}